WATCH: Biogen CEO Michel Vounatsos to step down after the U.S. government's Medicare program restricts coverage of its Alzheimer's drug Aduhelm to patients in clinical trials https://t.co/SUaPi3e4Yw pic.twitter.com/rvNETpnsg5— Reuters (@Reuters) May 8, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


